Regencell Bioscience Holdings Ltd (RGC): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

494.49M
Year ended 2025-06-30
+238.0%
3-year compound annual growth
+118.2%
5-year compound annual growth
2020-06-30: 10.00M2021-06-30: 10.00M2022-06-30: 12.81M2023-06-30: 13.01M2024-06-30: 13.01M2025-06-30: 494.49M494.49M
2020-06-30 Weighted Average Diluted Shares (shares) 2025-06-30
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-06-30494.49Mn/m2025-10-31, From 2024-07-01
2024-06-3013.01M0.0%2024-10-25, From 2023-07-01
2023-06-3013.01M+1.6%2024-10-25, From 2022-07-01
2022-06-3012.81M+28.1%2024-10-25, From 2021-07-01
2021-06-3010.00M0.0%2023-10-27, From 2020-07-01
2020-06-3010.00Mn/a2022-10-31, From 2019-07-01